Henry Schein, Inc. (NASDAQ:HSIC) Shares Bought by Geode Capital Management LLC

Geode Capital Management LLC boosted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 0.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,169,033 shares of the company's stock after buying an additional 14,876 shares during the period. Geode Capital Management LLC owned approximately 2.54% of Henry Schein worth $218,762,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in HSIC. Smartleaf Asset Management LLC grew its stake in shares of Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after buying an additional 143 shares in the last quarter. CIBC Asset Management Inc boosted its holdings in shares of Henry Schein by 1.0% in the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock worth $1,235,000 after purchasing an additional 169 shares during the period. Metis Global Partners LLC increased its position in shares of Henry Schein by 4.7% during the 4th quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock valued at $291,000 after purchasing an additional 187 shares during the last quarter. Central Pacific Bank Trust Division lifted its position in Henry Schein by 2.0% in the fourth quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company's stock worth $706,000 after buying an additional 200 shares during the last quarter. Finally, Sanctuary Advisors LLC boosted its stake in Henry Schein by 5.0% during the fourth quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company's stock worth $294,000 after buying an additional 203 shares during the period. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Performance

Henry Schein stock traded down $3.16 during mid-day trading on Thursday, hitting $63.00. The company had a trading volume of 509,125 shares, compared to its average volume of 1,870,227. The company's fifty day moving average is $72.55 and its 200-day moving average is $72.32. The company has a market capitalization of $7.82 billion, a price-to-earnings ratio of 25.97, a P/E/G ratio of 2.13 and a beta of 0.84. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm's revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.66 earnings per share. Equities research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on HSIC shares. Wells Fargo & Company assumed coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective on the stock. UBS Group reduced their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. StockNews.com raised Henry Schein from a "hold" rating to a "buy" rating in a research report on Wednesday. Jefferies Financial Group boosted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Finally, Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and lifted their price objective for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Five equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein currently has an average rating of "Moderate Buy" and an average target price of $81.10.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.